A paper describing the potentials of Nichi Glucan as a vaccine adjuvant to COVID-19 has been published in Human Vaccines and Immunotherapeutics, a journal sponsored by the International Society of Vaccines.
Clinical studies in Covid-19 and its variants to tackle the pandemic, recommended.
To read the press release in Business Wire, click here.
Please visit nichiglucan.com for more information about Nichi Glucan.
Cliny PEG Gastrostomy kits of Create Medic launched in India by Medinippon, GNCorp sister company 11Aug2023 Ja
Japanese scientists, research collaborators to Nichi-in Centre for Regenerative Medicine (NCRM) have reported an increased yield of Beta 1,3-1,6 glucans in the produc
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome
Manuscript published in Stem Cell Reviews and Reports
“neu REFIX ” potentials in Duchenne Muscular Dystrophy will be presented at Congress held in UAE
“Nichi Glucan” and “Nichi BRITE” potentials will be presented at an academic conference in Osaka, Japan
A curiosity driven sojourn, across disciplines in science, led to the discovery of a safe adjuvant hidden in a beta glucan giving hope to patients with muscular dystrophy; A story of ZeitenWende all along, blessed with good people, hopefully a modest contribution to humanity by connecting the dots.
Published in Scientific Reports, a nature portfolio journal 15 November 2023 Significant reduction of muscle f
